Literature DB >> 28843052

Hypercalcaemia secondary to ectopic parathyroid hormone expression in an adolescent with metastatic alveolar rhabdomyosarcoma.

Rachael Brooks1, Christopher Lord2, Justin H Davies3, Juliet C Gray1,4.   

Abstract

We report the case of a 14-year-old male with metastatic alveolar rhabdomyosarcoma, presenting with hypercalcaemia (3.89 mmol/l) and elevated parathyroid hormone (PTH) level (10.2 pmol/l). Imaging demonstrated extensive bony lytic damage, with "floating teeth" in the mandible. Normalisation of calcium levels and bony reformation of the mandible occurred following chemotherapy; PTH levels decreased initially but remained above normal levels. Imaging did not demonstrate any evidence of parathyroid abnormality. Tumour ectopic PTH secretion is a very rare cause of hypercalcaemia of malignancy in children. Hypercalcaemia with an elevated PTH, in the absence of parathyroid-related cause, should prompt investigation for underlying malignancy.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  alveolar rhabdomyosarcoma; ectopic parathyroid hormone; hypercalcaemia

Mesh:

Substances:

Year:  2017        PMID: 28843052     DOI: 10.1002/pbc.26778

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  1 in total

1.  Hypercalcemia of Malignancy: Simultaneous Elevation in Parathyroid Hormone-Related Peptide and 1,25 Dihydroxyvitamin D in Sarcoma.

Authors:  Dong Won Kim; Ann Miller; Andrew Li; Naomi Hardy; Kristi D Silver
Journal:  AACE Clin Case Rep       Date:  2021-01-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.